Weekly Dose: teriparatide, the osteoporisis drug that forms new bone
- Written by Peter Robert Ebeling, Head, Department of Medicine, School of Clinical Sciences; Professor of Medicine, Monash University

Teriparatide is an injectable drug to treat severe osteoporosis, a condition where mineral loss causes the bones to become brittle and to fracture easily.
Teriparatide improves bone strength by stimulating the formation of new bone. It does this by increasing...